The 2019 Automation SIG identified some of the biggest opportunities to improve manufacturing efficiency and accuracy. This report comprises 14...

A panel of advanced therapy manufacturing experts explore strategies to overcome the global manufacturing shortage

A summary of Dr Shirley O'Dea's presentation and data from Phacilitate Leaders Europe

Episode six with Jana Stoudemire, Chief Commercialisation Officer, Space Tango

Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where to access ...

Charter Medical's President on automation and tubing standardisation

Paragon Bioservice's Chief Commercial Officer on being acquired by Catalent and the future of the contract manufacturing landscape

Learn more about the background of helper plasmids, their application, regulatory considerations and advantages. Hosted by Aldevron.

Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019...

Panellists from Invetech, bluebird bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the...

From CRISPR patent wars, IPOs and acquisitions to major deals in China; what would be on your top ten list of 2018?

An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics

An interview with J. Kelly Ganjei, CEO and Chairman of the Board, Cognate BioServices, Inc

The production shortfall for cell therapies and viral vectors could have a devastating effect on the growth and success of the industry but...

As we see more cell and gene therapies gaining market authorisation, attention is turning to the bioprocesses used for their manufacture,...